Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
1920 ARTÍCULOS , VIENDO DEL 1 AL 15
The Effect of Bacterial Composition Shifts in the Oral Microbiota on Alzheimer's Disease
Moghadam MT, Mojtahedi A, Bakhshayesh B, Babakhani S, Ajorloo P, Shariati A, Mirzaei M, Heidarzadeh S, Jazi FM.
Curr Mol Med. 2024;24(2):167-181. doi: 10.2174/1566524023666220819140748.
Ali MU, Anwar L, Ali MH, Iqubal MK, Iqubal A, Baboota S, Ali J.
CNS Neurol Disord Drug Targets. 2024;23(7):819-840. doi: 10.2174/1871527322666221223091529.
Effect of Natural Plant Products on Alzheimer's Disease
Varshney H, Siddique YH.
CNS Neurol Disord Drug Targets. 2024;23(2):246-261. doi: 10.2174/1871527322666230228102223.
Telecaregiving for Dementia: A Mapping Review of Technological and Nontechnological Interventions
Hill JR, Min EE, Abebe E, Holden RJ.
Gerontologist. 2024 Jan 1;64(1):gnad026. doi: 10.1093/geront/gnad026.
Gao Y, Guo J, Zhang F, Li Y.
Comb Chem High Throughput Screen. 2024;27(1):40-47. doi: 10.2174/1386207326666230419095813.
Phytocannabinoids as Potential Multitargeting Neuroprotectants in Alzheimer's Disease
Rathod SS, Agrawal YO.
Curr Drug Res Rev. 2024;16(2):94-110. doi: 10.2174/2589977515666230502104021.
Emerging Nanotechnology for the Treatment of Alzheimer's Disease
Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R, Maheshwari S, Shariq M, Parveen S, Shamim A.
CNS Neurol Disord Drug Targets. 2024;23(6):687-696. doi: 10.2174/1871527322666230501232815.
Cholinergic Transporters Serve as Potential Targets in Alzheimer's Disease
Bist R, Bhatt DK.
Curr Mol Med. 2024;24(4):397-398. doi: 10.2174/1566524023666230505155302.
Is There a Role of Vitamin D in Alzheimer's Disease?
Plantone D, Pardini M, Caneva S, De Stefano N.
CNS Neurol Disord Drug Targets. 2024;23(5):545-553. doi: 10.2174/1871527322666230526164421.
Targeting Cellular Senescence: A Potential Therapeutic approach for Alzheimer's Disease
Singh S, Bhatt LK.
Curr Mol Pharmacol. 2024;17:e010623217543. doi: 10.2174/1874467217666230601113430.
De Marchi F, Vignaroli F, Mazzini L, Comi C, Tondo G.
CNS Neurol Disord Drug Targets. 2024;23(5):614-627. doi: 10.2174/1871527322666230608110201.
Amyloid Precursor Protein: A Regulatory Hub in Alzheimer's Disease
Chen J, Chen JS, Li S, Zhang F, Deng J, Zeng LH, Tan J.
Aging Dis. 2024 Feb 1;15(1):201-225. doi: 10.14336/AD.2023.0308.
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease
Singh S, Agrawal N, Goyal A.
CNS Neurol Disord Drug Targets. 2024;23(3):384-394. doi: 10.2174/1871527322666230627123426.
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
Nasb M, Tao W, Chen N.
Aging Dis. 2024 Feb 1;15(1):43-73. doi: 10.14336/AD.2023.0608.
Aducanumab in Alzheimer's Disease: A Critical Update
Ashique S, Sirohi E, Kumar S, Rihan M, Mishra N, Bhatt S, Gautam RK, Singh SK, Gupta G, Chellappan DK, Dua K.
Curr Med Chem. 2024;31(31):5004-5026. doi: 10.2174/0929867331666230727103553.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.